Anemia of cancer in intermediate-grade non-Hodgkin's lymphoma

Southern Medical Journal

Volumn 95, Issue 8, 2002, Pages 889-896

  Morrow, Thomas J ^a   Volpe, Salvatore ^a   Gupta, Sanjay ^a   Tannous, Rima E ^a   Fridman, Moshe ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; HEMOGLOBIN; PREDNISONE; VINCRISTINE;

ADULT; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA;

EID: 0036340387     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200295080-00021     Document Type: Article

References (34)

1. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by γ-interferon
2. Suppression of normal human erythropoiesis by γ interferon in vitro
3. Cancer-related anemia: Its causes and characteristics
4. Decreased erythropoietin response in patients with the anemia of cancer
5. Anemia in cancer
6. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys
7. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
8. Frequency and significance of anemia in non-Hodgkin's lymphoma patients
9. Implications of the anemia of cancer disorders in patients anticipating radiotherapy
10. Primary radiotherapy of larynx and pharynx carcinoma. An analysis of some factors influencing local control and survival
11. Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer
12. Influence of pretreatment serum hemoglobin levels on survival in epithelial ovarian cancer: A prospective review
13. Pretreatment hemoglobin level influences local control and survival of TI-T2 squamous cell carcinomas of the glottic larynx
14. Impact of anemia in patients with head and neck cancer
15. Chemotherapy-induced anemia in adults: Incidence and treatment
16. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas
17. Prognosis and treatment of lymphoblastic lymphoma in adults: A report on 80 patients
18. Significance of hematological parameters in the non-Hodgkin's malignant lymphomas
19. Nodular malignant lymphomas. Factors affecting complete response rate and survival
20. Follicular lymphoma: Prognostic factors for response and survival
21. LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma
22. Prognostic factors in high and intermediate-grade non-Hodgkin's lymphoma
23. Effect on age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience
24. Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma
25. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: Results of a tree-structured survival analysis
26. Clinical significance of hematologic parameters in non-Hodgkin's lymphoma at diagnosis
27. Bone marrow involvement in non-Hodgkin's lymphoma, implications for staging and therapy
28. Relevance of oxygen in radiation therapy. Mechanisms of action, correlation to low hemoglobin levels
29. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: A risk model
30. The identification of discrete prognostic groups in low-grade non-Hodgkin's lymphoma
31. High-grade non Hodgkin's lymphoma treated in northern Norway. Treatment, outcome, and prognostic factors
32. Small lymphocytic lymphoma: A clinicopathologic analysis of 268 cases
33. Non-Hodgkin's lymphoma in Saskatchewan: A review of 10 years' experience
34. Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma: A randomized prospective study with an assessment of prognostic factors